| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 178 | 198 | 193 | 203 | 205 | 225 | 225 | 210 | 146 | 291 | 279 | 294 | 346 | 308 | 296 | 312 | 283 | 305 | 292 | 284 | 280 | 310 | 293 | 334 | 316 | 353 | 325 | 352 |
| Expenses | 132 | 146 | 142 | 145 | 156 | 161 | 159 | 173 | 131 | 198 | 188 | 195 | 224 | 212 | 218 | 231 | 211 | 221 | 215 | 212 | 214 | 234 | 226 | 251 | 235 | 260 | 251 | 283 |
| EBITDA | 46 | 53 | 51 | 58 | 49 | 64 | 66 | 37 | 15 | 94 | 90 | 99 | 122 | 96 | 78 | 81 | 72 | 83 | 77 | 72 | 66 | 76 | 67 | 83 | 81 | 93 | 75 | 69 |
| Operating Profit % | 25 % | 25 % | 26 % | 28 % | 24 % | 28 % | 29 % | 16 % | 8 % | 32 % | 32 % | 33 % | 31 % | 30 % | 26 % | 24 % | 24 % | 26 % | 25 % | 25 % | 23 % | 24 % | 22 % | 24 % | 25 % | 26 % | 22 % | 18 % |
| Depreciation | 5 | 5 | 5 | 5 | 8 | 9 | 11 | 11 | 10 | 11 | 11 | 14 | 13 | 15 | 17 | 18 | 21 | 22 | 23 | 23 | 21 | 22 | 25 | 26 | 26 | 27 | 28 | 29 |
| Interest | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 3 | 5 | 6 | 8 | 7 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 5 | 5 | 5 |
| Profit Before Tax | 42 | 48 | 46 | 52 | 39 | 53 | 53 | 23 | 4 | 81 | 78 | 82 | 103 | 78 | 56 | 57 | 43 | 55 | 48 | 42 | 39 | 48 | 37 | 51 | 51 | 61 | 42 | 36 |
| Tax | 14 | 18 | 14 | 17 | 12 | 10 | 11 | 8 | 1 | 21 | 19 | 20 | 28 | 19 | 15 | 16 | 9 | 14 | 12 | 8 | 10 | 13 | 10 | 14 | 13 | 15 | 11 | 7 |
| Net Profit | 27 | 30 | 31 | 35 | 27 | 43 | 42 | 16 | 3 | 61 | 59 | 61 | 75 | 58 | 41 | 40 | 34 | 41 | 36 | 34 | 29 | 36 | 27 | 37 | 38 | 47 | 32 | 29 |
| EPS in ₹ | 4.83 | 6.14 | 6.26 | 6.87 | 5.34 | 8.57 | 8.38 | 3.09 | 0.57 | 11.88 | 11.50 | 12.05 | 14.65 | 11.39 | 8.02 | 7.81 | 6.53 | 7.88 | 6.99 | 6.51 | 5.62 | 6.92 | 5.30 | 7.11 | 7.41 | 9.08 | 6.12 | 5.69 |
Metropolis Healthcare
1,677.30
+7.50
(0.45%)
There are new updates from the company18 hours ago
View
Market Cap
8,601.38 Cr
EPS
24.95
PE Ratio
59.54
Dividend Yield
0.00 %
Industry
Healthcare Services52 Week High
2,318.30
52 Week Low
1,315.00
PB Ratio
6.49
Debt to Equity
0.22
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from16 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,818.80 | #1 23,562.84 | 48.90 | #1 2,295.80 | 11.52 | #1 362 | 81.24 | 59.23 | |
950.00 | 9,750.45 | 68.18 | 568.60 | 20.11 | 120 | 3.56 | 47.66 | |
1,677.30 | #3 8,601.38 | #9 59.54 | #3 1,216.80 | #10 4.59 | #2 129 | #8 -20.00 | 51.69 | |
1,019.10 | 5,400.56 | 58.64 | 581.30 | 8.63 | 70 | 25.58 | 70.24 | |
644.85 | 2,082.21 | 27.00 | 636.40 | 25.65 | 57 | 10.70 | 36.73 | |
337.35 | 1,756.94 | 53.74 | 222.30 | 14.77 | 23 | 33.33 | 64.60 | |
1,894.30 | 1,625.86 | 35.19 | 86.70 | 25.47 | 32 | 58.82 | 70.27 | |
272.10 | 865.56 | #1 8.33 | 1,436.10 | 35.04 | 6 | -1,081.25 | 55.27 | |
240.65 | 170.82 | 15.19 | 63.00 | #1 248.07 | 7 | #1 133.33 | 42.71 | |
108.50 | 75.58 | 58.67 | 36.90 | 6.34 | 1 | 0.00 | 39.97 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
4.59 %
Net Income Growth
-10.39 %
Cash Flow Change
6.87 %
ROE
-19.21 %
ROCE
-13.10 %
EBITDA Margin (Avg.)
-8.13 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 530 | 553 | 752 | 1,004 | 1,530 | 1,502 | 1,555 |
| Fixed Assets | 207 | 213 | 296 | 343 | 1,059 | 1,121 | 1,177 |
| Current Assets | 300 | 305 | 397 | 609 | 393 | 303 | 316 |
| Capital Work in Progress | 0 | 6 | 3 | 0 | 6 | 20 | 0 |
| Investments | 102 | 33 | 14 | 10 | 16 | 15 | 55 |
| Other Assets | 221 | 301 | 439 | 651 | 450 | 347 | 323 |
| Total Liabilities | 530 | 553 | 752 | 1,004 | 1,530 | 1,502 | 1,555 |
| Current Liabilities | 91 | 125 | 170 | 204 | 302 | 265 | 246 |
| Non Current Liabilities | 11 | 8 | 58 | 92 | 341 | 246 | 210 |
| Total Equity | 429 | 420 | 525 | 708 | 888 | 991 | 1,099 |
| Reserve & Surplus | 405 | 409 | 513 | 696 | 876 | 978 | 1,086 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 4 | 14 | -1 | 18 | 8 | 56 | 279 | -321 | 3 | -6 |
| Investing Activities | -56 | 96 | -86 | 1 | 36 | -104 | 63 | -736 | 48 | -89 |
| Operating Activities | 70 | 91 | 102 | 104 | 90 | 215 | 249 | 253 | 247 | 264 |
| Financing Activities | -10 | -174 | -17 | -87 | -118 | -55 | -33 | 163 | -292 | -181 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 50.38 % | 50.37 % | 50.33 % | 49.50 % | 49.79 % | 49.79 % | 49.76 % | 49.76 % | 49.75 % | 49.75 % | 49.74 % | 49.74 % | 49.67 % | 49.62 % | 49.43 % | 49.40 % | 48.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 24.29 % | 0.00 % | 18.90 % | 18.25 % | 18.56 % | 16.73 % | 15.29 % |
| DIIs | 15.34 % | 14.22 % | 11.77 % | 10.63 % | 15.32 % | 13.85 % | 11.88 % | 13.30 % | 13.64 % | 14.47 % | 16.86 % | 20.28 % | 24.86 % | 27.43 % | 28.02 % | 30.00 % | 30.30 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.95 % | 3.98 % | 4.24 % | 6.50 % | 9.14 % | 9.26 % | 9.45 % | 9.73 % | 8.53 % | 8.15 % | 7.78 % | 6.63 % | 5.24 % | 4.07 % | 3.54 % | 3.34 % | 3.84 % |
| Others | 30.33 % | 31.43 % | 33.66 % | 33.37 % | 25.75 % | 27.10 % | 28.91 % | 27.21 % | 28.08 % | 27.62 % | 1.32 % | 23.35 % | 1.33 % | 0.63 % | 0.45 % | 0.53 % | 1.68 % |
| No of Share Holders | 30,679 | 33,527 | 43,552 | 64,168 | 79,895 | 86,404 | 90,090 | 91,452 | 84,269 | 89,692 | 86,249 | 79,878 | 68,283 | 58,108 | 51,852 | 48,572 | 49,293 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 13.26 | 8 | 8 | 8 | 8 | 4 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 1.03 | 0.36 | 0.39 | 0.67 | 0.46 | 0.26 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 May 2025 |  Quarterly Result Announcement | NA | 13 May 2025 | 1,694.80 | 1,712.30 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 1,708.90 | 1,757.75 |
| 08 Nov 2024 | Quarterly Result Announcement | NA | 08 Nov 2024 | 2,119.10 | 2,112.60 |
| 21 Aug 2024 |  Annual General Meeting | NA | 21 Aug 2024 | 2,098.30 | 2,091.55 |
| 17 Nov 2023 |  Dividend | ₹ 4.00 /share | 17 Nov 2023 | 1,472.25 | 1,606.85 |
| 23 Feb 2023 | Dividend | ₹ 8.00 /share | 23 Feb 2023 | 1,289.35 | 1,348.60 |
| 22 Feb 2022 | Dividend | ₹ 8.00 /share | 21 Feb 2022 | 2,459.95 | 1,976.10 |
| 19 Feb 2021 | Dividend | ₹ 8.00 /share | 17 Feb 2021 | 2,163.55 | 2,011.85 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 hours ago
18 hours agoAnnouncement under Regulation 30 (LODR)-Updates on Acquisition4 days ago
4 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 13, 2025
May 13, 2025Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025May 13, 2025
May 13, 2025Board Meeting Outcome for For The Meeting Held Today (May 13 2025)May 13, 2025
May 13, 2025Board Meeting Outcome for For The Meeting Held Today (May 13 2025)May 13, 2025
May 13, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 09, 2025
May 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
May 08, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 18, 2025
Apr 18, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 07, 2025
Apr 07, 2025Announcement under Regulation 30 (LODR)-AcquisitionApr 07, 2025
Apr 07, 2025Business Update For Q4FY25Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Mar 29, 2025
Mar 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 29, 2025
Mar 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 29, 2025
Mar 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Mar 28, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Mar 28, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 22, 2025
Mar 22, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 17, 2025
Mar 17, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Monday March 17 2025Mar 17, 2025
Mar 17, 2025Grant Of Restrictive Stock Units Under The Metropolis - Restrictive Stock Unit Plan 2020Mar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 03, 2025
Mar 03, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Feb 24, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2025
Feb 11, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 10, 2025
Feb 10, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2025
Feb 04, 2025Technical Indicators
RSI(14)
Neutral 51.69
ATR(14)
Less Volatile 51.45
STOCH(9,6)
Neutral 46.46
STOCH RSI(14)
Neutral 47.18
MACD(12,26)
Bearish -2.90
ADX(14)
Weak Trend 15.99
UO(9)
Bearish 46.24
ROC(12)
Uptrend And Accelerating 0.02
WillR(14)
Neutral -40.34
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Tata Focused Equity Fund Direct - Growth | 223255 | 2.16% | 1.16% | 2.16% | Apr 2025 | |
 NJ ELSS Tax Saver Scheme Direct - Growth | 63879 | 4.22% | 0.97% | 0.68% | Apr 2025 | |
 JM Aggressive Hybrid Fund Direct-Growth | 100000 | 2.12% | 0.90% | 0.82% | Apr 2025 | |
 Franklin India Equity Hybrid Fund Direct-Growth | 51063 | 0.41% | 0.41% | 0.41% | Apr 2025 | |
 Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth | 0 | 0.00% | -0.36% | 0.00% | Apr 2025 | |
| Franklin India Balanced Advantage Fund Direct - Growth | 51063 | 0.33% | 0.33% | 0.33% | Apr 2025 | |
 UTI India Consumer Fund Direct-Growth | 0 | 0.00% | -0.31% | -0.64% | Apr 2025 | |
| UTI ELSS Tax Saver Fund Direct-Growth | 0 | 0.00% | -0.26% | -0.54% | Apr 2025 | |
 HDFC Pharma And Healthcare Fund Direct - Growth | 245782 | 2.51% | 0.25% | -0.03% | Apr 2025 | |
| Franklin India Pension Fund Direct-Growth | 7659 | 0.25% | 0.25% | 0.25% | Apr 2025 | |
| Tata Young Citizens Direct | 30000 | 1.44% | 0.20% | 0.31% | Apr 2025 | |
| UTI Dividend Yield Fund Direct-Growth | 278538 | 1.21% | 0.19% | 0.17% | Apr 2025 | |
 Sundaram Multi Cap Fund Direct-Growth | 170050 | 1.09% | 0.19% | 0.11% | Apr 2025 | |
| Franklin India Debt Hybrid Fund A Direct- Growth | 1916 | 0.16% | 0.16% | 0.16% | Apr 2025 | |
| UTI Value Fund Direct-Growth | 570763 | 1.01% | 0.16% | 0.20% | Apr 2025 | |
| UTI Healthcare Fund Direct-Growth | 100000 | 1.64% | 0.14% | 0.14% | Apr 2025 | |
 Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth | 67160 | 1.40% | 0.11% | 0.11% | Apr 2025 | |
| Tata India Pharma & Healthcare Fund Direct-Growth | 136636 | 1.90% | 0.10% | 0.79% | Apr 2025 | |
 Baroda BNP Paribas Flexi Cap Fund Direct - Growth | 90000 | 1.25% | -0.10% | -0.22% | Apr 2025 | |
 Kotak India EQ Contra Fund Direct-Growth | 223102 | 0.93% | 0.09% | 0.31% | Apr 2025 | |
| Kotak Small Cap Fund Direct-Growth | 1085864 | 1.16% | 0.08% | 0.10% | Apr 2025 | |
 LIC MF Healthcare Fund Direct - Growth | 11417 | 2.31% | 0.08% | 0.31% | Apr 2025 | |
 DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth | 13963 | 1.07% | 0.08% | 0.00% | Apr 2025 | |
| Aditya Birla Sun Life Retirement Fund - The 50s Plan Direct-Growth | 1500 | 0.98% | 0.07% | 0.98% | Apr 2025 | |
| Sundaram ELSS Tax Saver Fund Direct | 98000 | 1.26% | 0.07% | 0.08% | Apr 2025 |
About Metropolis Healthcare
Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical laboratories, including a global reference laboratory in Mumbai, regional reference laboratories, satellite laboratories, and express laboratories. Metropolis provides services to both B2B and B2C markets, covering 197 cities in India and has operations in several African countries. The company offers approximately 3,487 clinical laboratory tests and 530 profiles, and has expanded its network through acquisitions and mergers. Metropolis is known for its quality diagnostics and has received awards for customer service and healthcare excellence.
Listing Date
15 Apr, 2019(6 Years,
13 days)
Chairperson NameAmeera Sushil Shah
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
